Clinical Trials Browser

Nasopharyngeal Neoplasms × Nivolumab × Clear all

NCT04875611 2025-04-24

NIVONASO-21

Phase 2 Recruiting

Nasopharyngeal Neoplasms

NCT06019130 2024-05-16

NPC-Nivo

Phase 2 Recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT02339558 2019-09-13

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Phase 2 Completed

45 enrolled 12 charts

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms